Experience. Commitment. Results.
AdTheorent Holding Company, Inc. (Nasdaq: ADTH), relating to its proposed merger with Cadent, LLC. Under the terms of the agreement, AdTheorent Holding Company shareholders will receive $3.21 in cash for each share they own.
The Aaron’s Company, Inc. (NYSE: AAN), relating to its proposed merger with IQVentures Holdings, LLC. Under the terms of the agreement, The Aaron’s Company shareholders will receive $10.10 in cash for each share they own.
PowerSchool Holdings, Inc. (NYSE: PWSC), relating to its proposed merger with Bain Capital Private Equity, LP. Under the terms of the agreement, PowerSchool Holdings, Inc. will receive $22.80 in cash for each share they own.
Diamond Offshore Drilling, Inc. (NYSE: DO), relating to its proposed merger with Noble Corp plc. Under the terms of the agreement, each share of Diamond Offshore Drilling stock will be converted into the right to receive $5.65 in cash and 0.2316 shares of Noble stock.
ICC Holdings, Inc. (NASDAQ: ICCH), relating to its proposed merger with Mutual Capital Holdings, Inc., and Mutual Capital Merger Sub, Inc. Under the terms of the agreement, ICC Holdings shareholders will receive $23.50 in cash for each share they own.
Southern California Bancorp (NASDAQ: BCAL), relating to its proposed merger with California BanCorp. Under the terms of the agreement, Southern California Bancorp shareholders will own approximately 57.1% of outstanding shares of the combined company.
Asensus Surgical, Inc. (NYSE: ASXC), relating to its proposed merger with KARL STORZ Endoscopy-America, Inc., a wholly owned direct subsidiary of KARL STORZ SE & Co. KG. Under the terms of the agreement, KARL STORZ Endoscopy-America, Inc., and Karl Storz California Inc. will acquire each outstanding share of Asensus Surgical stock for $0.35 in cash, without … Read more
American Strategic Investment Company (NYSE: NYC), relating to a tender offer from Bellevue Capital Partners, LLC. Under the terms of the agreement, Bellevue Capital Partners offers to purchase American Strategic Investment stock in the amount of $10.25 per share.
Calliditas Therapeutics AB (NASDAQ: CALT), relating to a tender offer from Asahi Kasei Corporation. Under the terms of the offer, Asahi Kasei Corporation will acquire all the outstanding shares of Calliditas stock for SEK 0.04 in cash per ADS.
Akili, Inc. (NASDAQ: AKLI), relating to its proposed merger with Vital Therapeutics Corporation. Under the terms of the agreement, Vital Therapeutics Corporation will acquire all the outstanding shares of Akili common stock for $0.4340 cash per share.